XORTX Therapeutics Statistics Share Statistics XORTX Therapeutics has 3.79M
shares outstanding. The number of shares has increased by 30.47%
in one year.
Shares Outstanding 3.79M Shares Change (YoY) 30.47% Shares Change (QoQ) 8.81% Owned by Institutions (%) 0.65% Shares Floating 3.62M Failed to Deliver (FTD) Shares 3,581 FTD / Avg. Volume 2.97%
Short Selling Information The latest short interest is 19.7K, so 0.38% of the outstanding
shares have been sold short.
Short Interest 19.7K Short % of Shares Out 0.38% Short % of Float 0.39% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.68 and the forward
PE ratio is -1.68.
XORTX Therapeutics's PEG ratio is
-0.01.
PE Ratio -0.68 Forward PE -1.68 PS Ratio 0 Forward PS 0.6 PB Ratio 0.97 P/FCF Ratio -0.87 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for XORTX Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.53,
with a Debt / Equity ratio of 0.01.
Current Ratio 3.53 Quick Ratio 3.53 Debt / Equity 0.01 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.38M Employee Count 2 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -48.39% in the
last 52 weeks. The beta is -0.05, so XORTX Therapeutics's
price volatility has been lower than the market average.
Beta -0.05 52-Week Price Change -48.39% 50-Day Moving Average 0.82 200-Day Moving Average 0.94 Relative Strength Index (RSI) 43.54 Average Volume (20 Days) 120,544
Income Statement
Revenue n/a Gross Profit n/a Operating Income -3.59M Net Income -4.76M EBITDA -3.71M EBIT -3.76M Earnings Per Share (EPS) -1.65
Full Income Statement Balance Sheet The company has 2.47M in cash and 38.78K in
debt, giving a net cash position of 2.43M.
Cash & Cash Equivalents 2.47M Total Debt 38.78K Net Cash 2.43M Retained Earnings -21.17M Total Assets 2.74M Working Capital 553.07K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -3.68M
and capital expenditures -38.92K, giving a free cash flow of -3.72M.
Operating Cash Flow -3.68M Capital Expenditures -38.92K Free Cash Flow -3.72M FCF Per Share -1.29
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields XRTX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for XRTX.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 14, 2023. It was a
backward
split with a ratio of 1:9.
Last Split Date Nov 14, 2023 Split Type backward Split Ratio 1:9
Scores Altman Z-Score -11.64 Piotroski F-Score 0
